The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPathfinder Minerals Regulatory News (PFP)

  • This share is currently suspended. It was suspended at a price of 0.275

Share Price Information for Pathfinder Minerals (PFP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.275
PFP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

3 Jan 2020 11:20

RNS Number : 7119Y
Pathfinder Minerals Plc
03 January 2020
 

3 January 2020

 

Pathfinder Minerals Plc

 

("Pathfinder" or the "Company")

 

Corporate Update

 

Pathfinder (AIM: PFP) is pleased to provide an update on its progress towards restoring an interest in Mining Concession 4623C in Mozambique (the "Licence") and on other (unconnected) commercial opportunities that have been presented to the Board of Directors of Pathfinder (the "Board") to assess.

 

As announced on 24 October 2019, a period of meetings took place in both South Africa and Mozambique in that month between members of the Board, its representatives and various key stakeholders involved in the process of working to secure a resolution of the issues surrounding the Company's previous interest in the Licence. Since then, two further rounds of meetings have been undertaken by Board representatives in Mozambique and South Africa to intensify the progress and further meetings are planned for this month.

 

A number of additional meetings have been conducted with the preferred funding partner which, as announced on 24 October 2019, is both technically competent and has the means to fund both a settlement itself and future development costs associated with the Licence. The party is continuing with its due diligence process. In addition, further dialogue has been conducted with the shareholders of Pathfinder Moçambique S.A. (the current Licence holder) with a view to concluding a mutually acceptable settlement in respect of the Licence. These discussions continue in good faith and have been facilitated by Africa Focus Group ("AFG") at every stage.

 

The Company announced on 24 October 2019 that the agreement with AFG was extended until 31 December 2019 and, given the ongoing progress that continues to be made with all parties, the Board has determined it in the interests of the Company to extend this agreement for a further three months on a non-exclusive basis. This allows the Board to explore other funding avenues unilaterally and to pursue other commercial opportunities where there is a clear synergy with the Board's expertise and the Company's natural resource focus. All other terms of the agreement with AFG remain the same.

 

As previously stated, while the Board remains confident of a successful resolution of the dispute surrounding the Licence, there is no certainty that this can be achieved to the satisfaction of all stakeholders within a timely manner. As such, the Board believes that it is in the interests of the Company also to assess other appropriate commercial opportunities. Accordingly, the Board is actively assessing two independent opportunities, with due diligence on their suitability for Pathfinder now at an advanced stage. The key consideration in any decision-making is whether a broadening of interests beyond the Licence will assist the Board in recovering shareholder value and generating future additional value through cash generation that would alleviate the pressure for future, potentially dilutive, funding requirements associated with Pathfinder's prospective interest in the Licence. It is highly likely that any decision to be taken by the Board in respect of restoring an interest in the Licence and/or pursuing other such opportunities would require the approval of shareholders by way of a General Meeting.

 

John Taylor, Chief Executive Officer of Pathfinder, commented:

 

"I continue to be encouraged by the progress made since our last update which reflects the considerable efforts of my fellow directors in relentlessly pursuing a successful outcome to the recovery of an interest in the Licence. In addition, I believe the strategic decision to also explore wider commercial interests is the correct course of action to take. The Board's focus remains firmly on a successful resolution of the long-running dispute over the Licence and consideration of wider opportunities will not detract from that priority. I look forward to updating shareholders on further progress across a number of fronts."

 

Enquiries:

Pathfinder Minerals Plc

John Taylor, Chief Executive Officer

Tel. +44 (0)20 3440 7775

 

Strand Hanson Limited (Nominated & Financial Adviser and Broker)

James Spinney / Ritchie Balmer / Jack Botros

Tel. +44 (0)20 7409 3494

 

Vigo Communications (Public Relations)

Ben Simons / Simon Woods

Tel. +44 (0)20 7390 0234

Email. pathfinderminerals@vigocomms.com

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFXLFBBFLFBBD
Date   Source Headline
16th Apr 20247:00 amRNSUpdate on proposed acquisition of Rome Resources
4th Apr 20247:00 amRNSUpdate in relation to £1.275 million subscription
28th Mar 20246:05 pmRNSHolding(s) in Company
27th Feb 20247:00 amRNSUpdate on Rome Resources
29th Jan 202410:21 amRNSAmendment to the revised IM Minerals SPA
2nd Jan 202410:00 amRNSHolding(s) in Company
29th Dec 20231:00 pmRNSTotal Voting Rights
22nd Dec 20239:56 amRNSSubscription to raise £1.275 million and TVR
21st Dec 20235:05 pmRNSResult of General Meeting
4th Dec 20237:00 amRNSNotice of GM
29th Nov 20237:30 amRNSSuspension - Pathfinder Minerals PLC
29th Nov 20237:00 amRNSProposed Acquisition, Subscription & Suspension
3rd Nov 202312:56 pmRNSHolding in Company
26th Sep 20237:00 amRNSHalf-Year Results
1st Sep 20237:00 amRNSProposed Bonus Shares Timetable
18th Aug 20231:42 pmRNSResult of GM & Completion of Disposal
16th Aug 20237:00 amRNSBoard Changes & Proposed Issue of Bonus Shares
31st Jul 20237:00 amRNSNotice of GM
28th Jul 20234:14 pmRNSEntry into revised SPA for sale of IM Minerals
26th Jul 20237:00 amRNSChange of Nominated Adviser and Broker
4th Jul 20234:07 pmRNSHolding(s) in Company
23rd Jun 20237:00 amRNSResult of AGM and Board Changes
19th Jun 20235:04 pmRNSHolding(s) in Company
14th Jun 20234:27 pmRNSUpdate re Sale of IM Minerals
30th May 20233:14 pmRNSUpdate re Sale of IM Minerals
25th May 20237:01 amRNSNotice of AGM
25th May 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSUpdate re Sale of IM Minerals
11th May 20235:00 pmRNSUpdate re Sale of IM Minerals: Result of Meeting
28th Apr 20237:25 amRNSAmendment to Share Option Terms
21st Apr 20237:00 amRNSRevised SPA, Posting of Circular and Notice of GM
12th Apr 20237:00 amRNSUpdate re Sale of IM Minerals
22nd Mar 20232:05 pmRNSSecond Price Monitoring Extn
22nd Mar 20232:00 pmRNSPrice Monitoring Extension
22nd Mar 20237:00 amRNSSPA Signed for Sale of IM Minerals
22nd Feb 20237:00 amRNSUpdate re Sale of IM Minerals
2nd Feb 202311:14 amRNSHolding(s) in Company
1st Feb 20237:01 amRNSUpdate re Bilateral Investment Treaty Claim
1st Feb 20237:00 amRNSPlacing Completion and Total Voting Rights
27th Jan 20235:12 pmRNSResult of General Meeting
9th Jan 20237:00 amRNSNotice of GM
4th Jan 20237:00 amRNSUpdate re Bilateral Investment Treaty Claim
3rd Jan 20237:00 amRNSConditional Placing to Raise £0.5 Million
28th Dec 20223:44 pmRNSUpdate re Loan Agreement
8th Nov 20225:26 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSHalf-year Results
29th Sep 20227:02 amRNSLoan Agreement
29th Sep 20227:00 amRNSUpdate re Bilateral Investment Treaty Claim
30th Jun 20224:14 pmRNSResult of Annual General Meeting
17th Jun 20224:58 pmRNSNotice of AGM Explanatory Notes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.